(Q36115945)

12 August 2017

Correlation between clinical response to interleukin 2 and HLA phenotypes in patients with metastatic renal cell carcinoma (English)

1 reference

metastatic renal cell carcinoma

12 August 2017

1 reference

1 reference

Bain C

1

1 reference

12 August 2017

Merrouche Y

2

1 reference

12 August 2017

Puisieux I

3

1 reference

12 August 2017

Blay JY

4

1 reference

12 August 2017

Negrier S

5

1 reference

12 August 2017

Bonadona V

6

1 reference

12 August 2017

Lasset C

7

1 reference

12 August 2017

Lanier F

8

1 reference

12 August 2017

Duc A

9

1 reference

12 August 2017

Gebuhrer L

10

1 reference

12 August 2017

Philip T

11

1 reference

12 August 2017

Favrot MC

12

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

75

1 reference

12 August 2017

2

1 reference

12 August 2017

283-286

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1997.46

12 August 2017

0 references

cites work

B7.1 gene transduction of human renal-cell-carcinoma cell lines restores the proliferative response and cytotoxic function of allogeneic T cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063266

HLA associations in the antitumor response against malignant melanoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063266

Cellular immune response to human renal-cell carcinomas: definition of a common antigen recognized by HLA-A2-restricted cytotoxic T-lymphocyte (CTL) clones

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063266

Interleukin-2 with or without LAK cells in metastatic renal cell carcinoma: a report of a European multicentre study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063266

Home therapy with recombinant interleukin-2 and interferon-alpha 2b in advanced human malignancies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063266

Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063266

HLA linked resistance factors and survival in acute myelogenous leukemia

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063266

Tumor-specific lysis of human renal cell carcinomas by tumor-infiltrating lymphocytes. I. HLA-A2-restricted recognition of autologous and allogeneic tumor lines.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063266

Prolonged Survival in Bronchogenic Carcinoma Associated With HL-A Antigens W-19 and HL-A5: A Preliminary Report

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063266

Clinical application of retroviral gene transfer in oncology: results of a French study with tumor-infiltrating lymphocytes transduced with the gene of resistance to neomycin.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2063266

GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKAEMOGENESIS

23 September 2018

1 reference

12 December 2020

HLA antigens in renal cell carcinoma

1 reference

12 December 2020

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

12 December 2020

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

12 December 2020

Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma

1 reference

12 December 2020

HLA class I alleles and responsiveness of melanoma to immunotherapy with interferon-alpha (IFN-alpha) and interleukin-2 (IL-2)

1 reference

12 December 2020

Selective cytokine gene expression in renal cell carcinoma tumor cells and tumor-infiltrating lymphocytes

1 reference

12 December 2020

HLA-DQ1 is associated with clinical response and survival of patients with melanoma who are treated with interleukin-2

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1997.46

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

9010039

1 reference